IS-free Treg Stem Cell Transplant

A Pilot/Phase 1 Study of Immunosuppression-free Regulatory T-cell Graft-engineered Haploidentical Hematopoietic Cell Transplantation in Relapsed/Refractory AML/MDS

More Information

Trial Status
Accepting patients
Trial Phase
Phase 1
Enrollment
10 patients (estimated)
Sponsors
Dana-Farber Cancer Institute
Tags
Adoptive Cellular Therapy, Allogeneic Stem Cell Transplant, Chemotherapy, T Cell (Allogeneic), CD34, Radiation Therapy
Trial Type
Treatment
Last Update
4 weeks ago
SparkCures ID
1598
NCT Identifier
NCT04678401

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.